OVERVIEW

 37th Pharmacology Conference UK & EU is organized by Virtue Insight and will be held from Feb 12 - 13, 2025 at Sheraton Skyline Hotel London Heathrow, London, England, United Kingdom.

Description:
“Ensuring safer drugs to market. Latest developments in PV”

This event will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Take a chance and make it count by attending our event to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition.

KEY SPEAKERS:

  • FABIO DE GREGORIO, VP, Head of Drug Safety Europe, Shionogi Europe
  • ZINA SADEQ, Director, Regional PV & Alliance Management, Amicus Therapeutics
  • ROHAN MANE, Director, Safety Risk Management Centre of Excellence, Pfizer
  • VALENTINA MANCINI, Senior Director Pharmacovigilance, QPPV, Shionogi Europe
  • ABIDALI FAZAL, Safety Science Director, Roche
  • ERIKA BARBAROSIE, Associate Director Compliance R&D Quality, Gilead Sciences
  • MICHAEL BEAN, Senior Director, Regulatory Compliance, Johnson & Johnson
  • TANUJA HALADY, Senior Medical Director, Head of GPS Oncology Group III, Merck KGaA
  • TEA BABIC, Director, PV Audits and Inspections, Teva
  • EA MARIE HOLST, Director, Pharmacovigilance Compliance, Novo Nordisk
  • LEONARDO PEREIRA, Safety Director, Roche
  • YVONNE NANCIU, Country Head Pharmacovigilance Deputy EU QPPV, Bayer
  • STEPHANIE MILLICAN, Head of Immunology, Biocompatibility & Non-clinical Safety & Surveillance Group, MHRA
  • SABINE POLTERMANN, Head of Country Patient Safety Switzerland, Bristol-Myers Squibb
  • JOHN SOLOMON, Head of Pharmacovigilance - UK & Ireland, Sanofi
  • BEGUM BENLI PEKER, Head of Patient Safety Netherlands & EU Hub, Bristol-Myers Squibb
  • MINHAJ OBEIDULLAH, Global Head Governance & Risk, Novartis
  • LEA GALOVIC, Associate Director, Risk Management, Global Patient Safety & PV, Teva
  • MIRCEA CIUCA, Global Head Medical Safety, Organon
  • PAV RISHIRAJ, Director, Head of Pharmacovigilance, Ipsen
  • SUMIT MUNJAL, Global Head of Medical Safety, Otsuka Pharmaceuticals
  • RAJ BHOGAL, Sr. Director, R&D Business Strategy & Operations, Jazz Pharmaceuticals
  • ILARIA GRISONI, Exec Dir, Head of EU/INT PV & QPPV Office and EEA QPPV, Jazz Pharmaceuticals
  • MARK DANIELS, Director, Safety Physician, Medical Safety, Jazz Pharmaceuticals
  • RICHARD JELLEY, Sr Dir, Global Regulatory Strategy, Jazz Pharmaceuticals
  • CLAIRE BEGGS, Executive Director, Regulatory Affairs, INSPIRE, Jazz Pharmaceuticals
  • RAJ HANVESAKUL, Executive Director, Therapeutic Area Lead, Hematology/Oncology, Jazz Pharmaceuticals
  • TERESA SARAGOCA, Director, Regulatory Affairs & Technical Manager, ITALFARMACO
  • SUZANNE FONCIN, Head of Safety Analysis & Writing, UCB
  • PHILLIP EICHORN, Global Head of Drug Safety, Amryt Pharma
  • YUUNG YUUNG YAP, Head Legal Pharma Operations, Vifor Pharma
  • HEATHER MURPHY, Founder and CEO, HMGlobal Pharmacovigilance Consulting
  • RUDI SCHEERLINCK, Safety Strategy Lead – Oncology, Merck Group
  • MARGHERITA D’ANTUONO, EU-UK QPPV, Piramal
  • PETAR GJORGIEV, Global Safety Lead, Regeneron
  • PHILIP JONES, Disease Area Cluster Lead, CVMWH, SSRM, WMS, Pfizer
  • MARIANNE MOUNIR, Senior Global System Auditor, Bayer
  • SANJEEV SRIVASTAV, Signal Management Lead, BioNTech
  • ALEXANDER ROUSSANOV, International Partner, Life Sciences & Privacy, Arnold & Porter
  • SANDY EISEN, Chief Medical Officer, CNS Consult

Plus more joining soon

KEY THEMES DISCUSSED:

  • Market Trends - Critique & Ways Forward
  • Challenges / Opportunities
  • Patient Safety
  • RMP / REMS
  • Safety & Signal Detection
  • Automation in PV
  • Regulatory
  • Medical Devices
  • Impact of Technology AI, ML
  • Audits & Inspection
  • RWE / RWD
  • Outsourcing

SPONSORS:
Gold Sponsor - Cencora Pharmalex
Silver Sponsor - HM Global Pharmacovigilance Consulting

We have sponsorship opportunities available for the event, which gives you an opportunity to speak/exhibit, and create brand awareness. Here you can have a dedicated networking time, meet the leading international vendors and expand your knowledge of the latest business models.

KEY DATES

Event Start Date
12 Feb, 2025
Event Start Date
Event End Date
13 Feb, 2025
Event End Date

TARGET AUDIENCE

PharmacistClinical ResearchersHealthcare ManagementRegulatory affairsBio-Pharma CompaniesFormulation and Drug DeliveryPharmacoepidemiologyDrug Research & DevelopmentEpidemiologistsCEOs, CFOs, CMOs, CMIOs, CIOs, & CNOs

SPECIALITIES

PharmacologyGeriatricsGeriatric Medicine

SUGGESTED HOTELS

CONFERENCE VENUE

LocationSheraton Skyline Hotel London Heathrow
Heathrow Airport, Bath Rd, Hayes

RELATED CONFERENCES & LIVE WEBINARS

Apr 07 - 11, 2025 | St Pete Beach, ...

State required course for California ...
20 AMA PRA Category 1 Credit™ ...
More actions
US$749
By University Learning Systems (ULS)

Jun 10 - 12, 2025 | Las Vegas, Nevada,...

State required course for Arkansas ...
15 Contact Hours ...
More actions
US$199

Jun 23 - 26, 2025 | Myrtle Beach, ...

State required course for California ...
20 AMA PRA Category 1 Credit™ ...
More actions
US$749